Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jeffrey Tong
Antitumor Activity and Molecular Effects of the Novel Heat Shock Protein 90 Inhibitor, IPI-504, in Pancreatic Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Preclinical Antitumor Activity of SST0116CL1: A Novel Heat Shock Protein 90 Inhibitor
International Journal of Oncology
Cancer Research
Oncology
The Heat Shock Protein 90 Inhibitor IPI-504 Induces Apoptosis of AKT-dependent Diffuse Large B-Cell Lymphomas
British Journal of Haematology
Hematology
Activity of Dasatinib, a Dual SRC/ABL Kinase Inhibitor, and IPI-504, a Heat Shock Protein 90 Inhibitor, Against Gastrointestinal Stromal Tumor-Associated PDGFRAD842V Mutation
Clinical Cancer Research
Cancer Research
Oncology
The Heat Shock Protein 90 Inhibitor, (-)-Epigallocatechin Gallate, Has Anticancer Activity in a Novel Human Prostate Cancer Progression Model
Cancer Prevention Research
Medicine
Cancer Research
Oncology
Potent Activity of a Novel Dimeric Heat Shock Protein 90 Inhibitor Against Head and Neck Squamous Cell Carcinoma in Vitro and in Vivo
Clinical Cancer Research
Cancer Research
Oncology
Abrogation of Heat Shock Protein 70 Induction as a Strategy to Increase Antileukemia Activity of Heat Shock Protein 90 Inhibitor 17-Allylamino-Demethoxy Geldanamycin
Cancer Research
Cancer Research
Oncology
Crowding Activates Heat Shock Protein 90
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Heat Shock Protein 90 (HSP90AA1; Hsp90)
Science-Business eXchange
Heat Shock Protein 90 Inhibitors in the Treatment of Cancer: Current Status and Future Directions
Expert Opinion on Investigational Drugs
Medicine
Pharmacology
